Poolbeg Pharma PLC (LON:POLB – Get Free Report) traded up 17.3% during mid-day trading on Tuesday . The company traded as high as GBX 15.77 ($0.20) and last traded at GBX 15.70 ($0.20). 8,653,346 shares changed hands during mid-day trading, an increase of 291% from the average session volume of 2,212,504 shares. The stock had previously closed at GBX 13.39 ($0.17).
Poolbeg Pharma Stock Up 11.3 %
The stock has a market cap of £74.50 million, a P/E ratio of -1,490.00 and a beta of 2.27. The company’s 50 day moving average price is GBX 10.22 and its 200-day moving average price is GBX 9.36.
Insider Activity
In related news, insider Jeremy Skillington acquired 154,764 shares of the stock in a transaction dated Wednesday, February 21st. The stock was purchased at an average cost of GBX 11 ($0.14) per share, with a total value of £17,024.04 ($21,386.98). In other news, insider Cathal Friel purchased 830,000 shares of the business’s stock in a transaction dated Monday, February 19th. The stock was bought at an average price of GBX 12 ($0.15) per share, for a total transaction of £99,600 ($125,125.63). Also, insider Jeremy Skillington acquired 154,764 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The stock was purchased at an average cost of GBX 11 ($0.14) per share, with a total value of £17,024.04 ($21,386.98). Corporate insiders own 21.50% of the company’s stock.
Poolbeg Pharma Company Profile
Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass broad spectrum RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis.
See Also
- Five stocks we like better than Poolbeg Pharma
- 3 Stocks to Consider Buying in October
- Garmin Navigates to New Highs Driven By Wearables Trend
- Manufacturing Stocks Investing
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Best Aerospace Stocks Investing
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Poolbeg Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Poolbeg Pharma and related companies with MarketBeat.com's FREE daily email newsletter.